Enterovirus 68: Difference between revisions

Jump to navigation Jump to search
Alejandro Lemor (talk | contribs)
No edit summary
Alejandro Lemor (talk | contribs)
No edit summary
Line 5: Line 5:
{{Enterovirus 68}}
{{Enterovirus 68}}


{{SK}} EV68, EV-68, EV-D68
{{SK}} Enterovirus D-68, EV68, EV-68, EV-D68


==[[Enterovirus 68 overview|Overview]]==
==[[Enterovirus 68 overview|Overview]]==

Revision as of 17:39, 9 September 2014

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2];João André Alves Silva, M.D. [3]

Enterovirus 68 Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Risk Factors

Differentiating Enterovirus 68 from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Chest X Ray

CT Scan

MRI

Treatment

Medical Therapy

Surgery

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Enterovirus 68 On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Enterovirus 68

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Enterovirus 68

CDC on Enterovirus 68

Enterovirus 68 in the news

Blogs on Enterovirus 68

Directions to Hospitals Treating Enterovirus 68

Risk calculators and risk factors for Enterovirus 68

Synonyms and keywords: Enterovirus D-68, EV68, EV-68, EV-D68

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Enterovirus 68 from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray

Treatment

Medical Therapy | Primary Prevention | Future or Investigational Therapies

Case Studies

Case #1